BlockBeats News, April 30th, according to official sources, the DePIN project Kairos has completed its seed round financing, led by Vertex Capital (UK), HKIFS (Hong Kong), and Oaktree Capital Management (US) jointly.
Kairos is focused on building a DePIN resource network for the AI Agent era, aiming to bridge the collaborative path between edge hardware and intelligent body computing. Its flagship product is the world's first mass-produced blood pressure monitoring smart ring, accompanied by a distributed health data computing ecosystem.
It is reported that Kairos has achieved the large-scale implementation of medical-grade sensor modules, and the core team has a background in chip design and manufacturing. The project's data encryption architecture complies with the HIPAA medical compliance standard, demonstrating strong hardware delivery capabilities and a foundation of data security. Additionally, Kairos holds multiple core technology patents, including dual-system monitoring of blood pressure/blood lipids (TW112130535, CN202310968656.1, US184494,804), multi-sign fusion algorithm (TW114102843, CN202510101010.2), world's smallest medical-grade sensor module (TW114200663, CN202520109894.1), early screening algorithm for Parkinson's disease (TW114101216, CN202510041020.1), and a passive CIS fluidic system derived from missile fuel monitoring technology.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。